{"id":"https://openalex.org/W2225399376","doi":"https://doi.org/10.1021/acs.jmedchem.5b00992","title":"Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38","display_name":"Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38","publication_year":2015,"publication_date":"2015-08-12","ids":{"openalex":"https://openalex.org/W2225399376","doi":"https://doi.org/10.1021/acs.jmedchem.5b00992","mag":"2225399376","pmid":"https://pubmed.ncbi.nlm.nih.gov/26267483"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.5b00992","doi":"https://doi.org/10.1021/acs.jmedchem.5b00992","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00992","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022540344","display_name":"J. David Becherer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. David Becherer","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072238598","display_name":"Eric E. Boros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric E. Boros","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042599846","display_name":"Tiffany Y. Carpenter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiffany Y. Carpenter","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036466167","display_name":"David J. Cowan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Cowan","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080865895","display_name":"David N. Deaton","orcid":"https://orcid.org/0000-0001-6403-8305","observed_orcids":["https://orcid.org/0000-0001-6403-8305"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David N. Deaton","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041074563","display_name":"Curt D. Haffner","orcid":"https://orcid.org/0000-0002-7480-308X","observed_orcids":["https://orcid.org/0000-0002-7480-308X"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Curt D. Haffner","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048373508","display_name":"Michael R. Jeune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Jeune","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071635749","display_name":"Istvan W. Kaldor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Istvan W. Kaldor","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112016892","display_name":"James C. Poole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Chuck Poole","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052581089","display_name":"Frank Preugschat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Preugschat","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090134623","display_name":"Tara Rheault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tara R. Rheault","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067204217","display_name":"Christie A. Schulte","orcid":"https://orcid.org/0000-0002-0831-3656","observed_orcids":["https://orcid.org/0000-0002-0831-3656"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christie A. Schulte","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109986873","display_name":"Barry G. Shearer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry G. Shearer","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103495870","display_name":"Todd Shearer","orcid":"https://orcid.org/0009-0009-6106-2778","observed_orcids":["https://orcid.org/0009-0009-6106-2778"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd W. Shearer","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037531375","display_name":"Lisa M. Shewchuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa M. Shewchuk","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003695562","display_name":"Terrence L. Jr. Smalley","orcid":"https://orcid.org/0000-0001-5809-5864","observed_orcids":["https://orcid.org/0000-0001-5809-5864"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terrence L. Smalley","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078159096","display_name":"Eugene L. Stewart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugene L. Stewart","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051734758","display_name":"J. Darren Stuart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Darren Stuart","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085346149","display_name":"John C. Ulrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Ulrich","raw_affiliation_strings":["GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Research and Development, 5 Moore\rDrive, P.O. Box 13398, Research Triangle Park, North Carolina 27709, United States","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080865895"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.6126,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.93609515,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"58","issue":"17","first_page":"7021","last_page":"7056"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.8939999938011169,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.06599999964237213,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd38-inhibitors","display_name":"CD38 inhibitors","score":0.871999979019165},{"id":"https://openalex.org/keywords/nad-hydrolysis","display_name":"NAD+ hydrolysis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7630000114440918},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8140000104904175},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.8880000114440918},{"id":"https://openalex.org/keywords/enzyme-inhibitors","display_name":"enzyme inhibitors","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9405990839004517},{"id":"https://openalex.org/C2776309666","wikidata":"https://www.wikidata.org/wiki/Q408384","display_name":"Quinoline","level":2,"score":0.7548834085464478},{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.701701283454895},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6750219464302063},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.5807890892028809},{"id":"https://openalex.org/C2778327999","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Carboxamide","level":2,"score":0.5432892441749573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4871218204498291},{"id":"https://openalex.org/C159912055","wikidata":"https://www.wikidata.org/wiki/Q14885119","display_name":"CD38","level":4,"score":0.4740835428237915},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4610063433647156},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.32854121923446655},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.16793447732925415},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008567","descriptor_name":"Membranes, Artificial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009243","descriptor_name":"NAD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051997","descriptor_name":"ADP-ribosyl Cyclase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.5b00992","doi":"https://doi.org/10.1021/acs.jmedchem.5b00992","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.5b00992","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:26267483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26267483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1522767714","https://openalex.org/W1566643819","https://openalex.org/W1744273349","https://openalex.org/W1966100607","https://openalex.org/W1977242738","https://openalex.org/W1982008999","https://openalex.org/W1983754526","https://openalex.org/W2008764263","https://openalex.org/W2015615651","https://openalex.org/W2016222508","https://openalex.org/W2028058416","https://openalex.org/W2038879439","https://openalex.org/W2046080177","https://openalex.org/W2046827775","https://openalex.org/W2055614457","https://openalex.org/W2070162988","https://openalex.org/W2073022327","https://openalex.org/W2082340361","https://openalex.org/W2090442368","https://openalex.org/W2096780139","https://openalex.org/W2333241266","https://openalex.org/W2951438302","https://openalex.org/W4313379456"],"related_works":["https://openalex.org/W2794015317","https://openalex.org/W2333241266","https://openalex.org/W2096780139","https://openalex.org/W1978927321","https://openalex.org/W7162137028","https://openalex.org/W7212193029","https://openalex.org/W7100711566","https://openalex.org/W7155174071","https://openalex.org/W2015615651","https://openalex.org/W6977488499"],"abstract_inverted_index":{"Starting":[0],"from":[1],"the":[2,14,19,25,30,98,104,107],"micromolar":[3],"8-quinoline":[4],"carboxamide":[5],"high-throughput":[6],"screening":[7],"hit":[8],"1a,":[9],"a":[10,81],"systematic":[11],"exploration":[12],"of":[13,18,24,32,41,62,97,106,110,116],"structure-activity":[15],"relationships":[16],"(SAR)":[17],"4-,":[20],"6-,":[21],"and":[22,57,67,78],"8-substituents":[23],"quinoline":[26],"ring":[27],"resulted":[28],"in":[29,50,76,80,113],"identification":[31],"approximately":[33],"10-100-fold":[34],"more":[35],"potent":[36],"human":[37],"CD38":[38,64,99],"inhibitors.":[39],"Several":[40],"these":[42,63],"molecules":[43],"also":[44],"exhibited":[45],"pharmacokinetic":[46],"parameters":[47],"suitable":[48],"for":[49],"vivo":[51],"animal":[52],"studies,":[53],"including":[54],"low":[55,118],"clearances":[56],"decent":[58],"oral":[59],"bioavailability.":[60],"Two":[61],"inhibitors,":[65],"1ah":[66],"1ai,":[68],"were":[69],"shown":[70],"to":[71],"elevate":[72],"NAD":[73,111],"tissue":[74],"levels":[75],"liver":[77],"muscle":[79],"diet-induced":[82],"obese":[83],"(DIO)":[84],"C57BL/6":[85],"mouse":[86],"model.":[87],"These":[88],"inhibitor":[89],"tool":[90],"compounds":[91],"will":[92],"enable":[93],"further":[94],"biological":[95],"studies":[96],"enzyme":[100],"as":[101,103],"well":[102],"investigation":[105],"therapeutic":[108],"implications":[109],"enhancement":[112],"disease":[114],"models":[115],"abnormally":[117],"NAD.":[119]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}